Interventions for treating tuberculous pericarditis
Open Access
- 21 October 2002
- reference entry
- review article
- Published by Wiley
- No. 2,p. CD000526
- https://doi.org/10.1002/14651858.cd000526
Abstract
Tuberculous (TB) pericarditis is becoming more common. The infection can result in fluid around the heart, which can be fatal. To evaluate evidence from trials about the effects of medical and surgical treatments for TB pericarditis on death and life-threatening conditions. The Cochrane Infectious Diseases Group trials register, the Cochrane controlled trials register, Medline, Embase and reference lists of articles; contact with experts in the field. Randomised and quasi-randomised trials of treatments for TB pericarditis. Two reviewers independently assessed trial quality and extracted data. Meta-analysis using fixed effects models calculated summary statistics, provided there was no significant heterogeneity, and expressed results as relative risk. Three trials met the inclusion criteria, with a total of 411 participants. Treatments were adjuvant steroids and surgical drainage. Two small trials tested steroids. There were fewer deaths (all causes) in the intervention group, but the numbers were small and the result could have occurred by chance (relative risk [RR] 0.65, 95% confidence interval [CI] 0.36 to 1.16, n = 350). In one trial studying patients with effusion, "cure" was higher in the steroid group (alive and free of disability at 2 years (RR 0.69, 95% CI 0.29 to 0.80, n = 221). One trial examined open surgical drainage compared with conservative management, and showed no impact of surgery on death, but a protective effective against cadiac tamponade (RR 0.04, 95% CI 0.00 to 0.64). Steroids have potentially large impacts on survival, but trials are too small to test this. We believe further placebo controlled trials of steroids are warranted, exploring whether the presence of effusion or fibrosis modifies effects. Surgical options also require further evaluation.Keywords
This publication has 23 references indexed in Scilit:
- Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patientsHeart, 2000
- Corticosteroids in TuberculosisAnnals of Pharmacotherapy, 1996
- Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis.Circulation, 1994
- Corticosteroids and tuberculosis: risks and use as adjunct therapyTubercle and Lung Disease, 1993
- Tuberculous PericarditisPublished by American Medical Association (AMA) ,1991
- Pericardial disease and human immunodeficiency virus in Dar es Salaam, TanzaniaThe Lancet, 1990
- CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEIThe Lancet, 1988
- CONTROLLED TRIAL OF PREDNISOLONE AS ADJUVANT IN TREATMENT OF TUBERCULOUS CONSTRICTIVE PERICARDITIS IN TRANSKEIThe Lancet, 1987
- Tuberculous pericarditisJournal of Infection, 1980
- Tuberculous PericarditisAnnals of Internal Medicine, 1970